News

We are used to talk about Good Manufacturing Practice (GMP), however, have you thought the importance of the Good Laboratory Practice (GLP)? While GLP and GMP serve different purposes and address different stages of product development and manufacturing, they are both essential components of the regulatory framework governing the biopharmaceutical industry. GMP ensures the consistent… Continue reading Good Laboratory Practice (GLP)

We are pleased to announce that the development of our CDMO’s conceptual, basic and executive projects has begun! Last month we closed a partnership with PQE Group to develop the Conceptual, Basic and Executive projects of our CDMO. PQE Group is an ISO 9001 certified technology solutions and compliance consulting services company with global capabilities… Continue reading Partnership with PQE Group

The democratization of access to healing has been a transformative force in healthcare, aiming to ensure that quality medical services, medicines and treatments are accessible to a wider range of people around the world. And science plays an important role in this topic. The traditional model for developing biopharmaceutical products does not favor developing countries,… Continue reading Democratization of access to science and healing

Democratizing Access to Science: The Crucial Role of Contract Development and Manufacturing Organizations (CDMOs) in South America In the pursuit of global progress, the democratization of access to science stands as a pivotal objective. Contract Development and Manufacturing Organizations (CDMOs) have emerged as potent facilitators in this endeavor, playing a vital role in advancing scientific… Continue reading The Crucial Role of CDMOs in South America

In our last post, we talked about the CDMO importance (Why do we need a CDMO?). Now that it is clear, we need to understand what the key considerations are to choose the right CDMO for your process. Choosing a CDMO is something highly strategic and delicate, since the wrong choice can negatively impact the… Continue reading How to select the best CDMO for your needs?

During the past decade, a significant shift has been seen in the nature of the products manufactured and sold by the innovative biopharmaceutical industry. The global biopharmaceutical portfolio of today contains a greater prevalence of large molecule drugs, expansion in the number of personalized or targeted products, and a rise in treatments for many orphan… Continue reading Why do we need a CDMO?

In early 2023, we partnered with Sthorm to build the first CDMO for biopharmaceuticals in Brazil! Together we seek to develop new approaches to create a scenario where it is possible to democratize access to science and healing. That’s how we’re going to make a positive impact on people’s lives. With a new brand and a clear… Continue reading Biotimize’s New Era

The research, development and production of biological products has grown dramatically in recent years, and Brazil has accompanied this growth. To ensure the safety of these products, we need to implement quality rules that are standardized worldwide and recognized by our Health Surveillance Agency (ANVISA), and by international regulatory bodies. To ensure high quality research… Continue reading Biotimize in South Korea – GTH-B